Long-term survival with advanced ovarian cancer: An analysis of 5-year survivors in the Australian trial comparing combination versus sequential chlorambucil and cisplatin therapy
- 31 December 1992
- journal article
- clinical trial
- Published by Elsevier in Gynecologic Oncology
- Vol. 47 (3), 292-297
- https://doi.org/10.1016/0090-8258(92)90129-7
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Predictive factors for long-term survival in patients with advanced ovarian cancerGynecologic Oncology, 1989
- A meta-analysis of prognostic factors in advanced ovarian cancer with median survival and overall survival (measured with the log (relative risk)) as main objectivesEuropean Journal of Cancer and Clinical Oncology, 1989
- The Role of Surgical Reexploration Following Chemotherapy in Ovarian CancerAustralian and New Zealand Journal of Obstetrics and Gynaecology, 1988
- Ploidy assessment of benign and malignant ovarian tumors by flow cytometry. A clinicopathologic studyCancer, 1987
- Therapy of stage III (optimal) epithelial carcinoma of the ovary with melphalan or melphalan plus corynebacterium parvum (a gynecologic oncology group study)Gynecologic Oncology, 1986
- Prognostic factors in advanced ovarian carcinoma.Journal of Clinical Oncology, 1986
- Chemotherapy of advanced ovarian adenocarcinoma: A randomized comparison of combination versus sequential therapy using chlorambucil and cisplatinGynecologic Oncology, 1986
- Advanced ovarian carcinoma. Factors influencing survivalCancer, 1985
- Prognostic factors in malignant epithelial ovarian tumorsGynecologic Oncology, 1983
- Choice of postoperative therapy based on prognostic factorsInternational Journal of Radiation Oncology*Biology*Physics, 1982